Clinical Trial Update: A Study of HDM2024 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating HDM2024 in participants with advanced solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HDM2024

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING